![]() Halofantrine hydrochloride structure
|
Common Name | Halofantrine hydrochloride | ||
---|---|---|---|---|
CAS Number | 36167-63-2 | Molecular Weight | 536.885 | |
Density | 1.244g/cm3 | Boiling Point | 596.2ºC at 760mmHg | |
Molecular Formula | C26H31Cl3F3NO | Melting Point | N/A | |
MSDS | Chinese USA | Flash Point | 314.4ºC |
Use of Halofantrine hydrochlorideHalofantrine hydrochloride (SKF-102886) is a blocker of delayed rectifier potassium current via the inhibition of human-ether-a-go-go-related gene (HERG) channel and a potent antimalarial compound[1][2]. |
Name | Halofantrine Hydrochloride |
---|---|
Synonym | More Synonyms |
Description | Halofantrine hydrochloride (SKF-102886) is a blocker of delayed rectifier potassium current via the inhibition of human-ether-a-go-go-related gene (HERG) channel and a potent antimalarial compound[1][2]. |
---|---|
Related Catalog | |
Target |
Malaria[1].HERG channel[2]. |
References |
Density | 1.244g/cm3 |
---|---|
Boiling Point | 596.2ºC at 760mmHg |
Molecular Formula | C26H31Cl3F3NO |
Molecular Weight | 536.885 |
Flash Point | 314.4ºC |
Exact Mass | 535.142334 |
PSA | 23.47000 |
LogP | 9.44630 |
Storage condition | 2-8°C |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Hazard Statements | H413 |
---|---|
Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
RIDADR | NONH for all modes of transport |
RTECS | SF7790000 |
Effect of serum lipoproteins on stereoselective halofantrine metabolism by rat hepatocytes.
Chirality 24(7) , 558-65, (2012) Experimental hyperlipidemia has shown to decrease cytochrome P450 3A4 and 2C11 expression and to increase liver concentrations and the plasma protein binding of halofantrine (HF) enantiomers. The pres... |
|
Discordant temporal evolution of Pfcrt and Pfmdr1 genotypes and Plasmodium falciparum in vitro drug susceptibility to 4-aminoquinolines after drug policy change in French Guiana.
Antimicrob. Agents Chemother. 56(3) , 1382-9, (2012) Analysis of the evolution of drug target genes under changing drug policy is needed to assist monitoring of Plasmodium falciparum drug resistance in the field. Here we genotype Pfcrt and Pfdmr1 of 700... |
|
Using resin to generate a non-invasive intestinal bile-depleted rat model was unsuccessful.
Eur. J. Pharm. Sci. 47(2) , 347-51, (2012) The purpose of this study was to evaluate if a rat model, based upon co-administration of the anion-exchanging resin, cholestyramine, could replace surgery when evaluating the importance of bile on dr... |
9-phenanthrenemethanol, 1,3-dichloro-α-[2-(dibutylamino)ethyl]-6-(trifluoromethyl)-, hydrochloride |
UNII:2B7ENL644K |
3-(Dibutylamino)-1-[1,3-dichlor-6-(trifluormethyl)phenanthren-9-yl]propan-1-olhydrochlorid |
MFCD00879136 |
3-(Dibutylamino)-1-[1,3-dichloro-6-(trifluoromethyl)-9-phenanthryl]propan-1-ol hydrochloride (1:1) |
3-(dibutylamino)-1-[1,3-dichloro-6-(trifluoromethyl)phenanthren-9-yl]propan-1-ol hydrochloride |
EINECS 252-895-4 |
3-(dibutylamino)-1-[1,3-dichloro-6-(trifluoromethyl)phenanthren-9-yl]propan-1-ol hydrochloride (1:1) |
3-(Dibutylamino)-1-[1,3-dichloro-6-(trifluoromethyl)-9-phenanthryl]-1-propanol hydrochloride (1:1) |
9-Phenanthrenemethanol, 1,3-dichloro-α-[2-(dibutylamino)ethyl]-6-(trifluoromethyl)-, hydrochloride (1:1) |
Halofantrine hydrochloride |
3-(dibutylamino)-1-[1,3-dichloro-6-(trifluorométhyl)phénanthrén-9-yl]propan-1-ol chlorhydrate |
UNII:H77DL0Y630 |